Gentry et al. identified seven primary trochlear schwannomas among 250 patients, 3 of whom had neurofibromatosis type 2 (NF2) and 1 with neurofibromatosis type 1 (NF1) [33]. This evidence concerns the gene NF2 and schwannoma.